Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Talis Biomedical Corp
| Metric | Talis Biomedical Corp TLISHealthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$62M |
| Operating margin | −3131.0% |
| Net margin | −2905.7% |
| Return on equity | −89.7% |
| Return on assets | −65.5% |
| Return on capital (ROCE) | −77.8% |
| Debt / equity | 0.37× |
| Revenue growth (YoY) | −55.7% |
| Altman Z″ (distress) | -15.72 |
| Accruals / assets | −9.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.